716017002: Idarucizumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Antidote (substance)\Idarucizumab (substance)
\Drug or medicament (substance)\Monoclonal antibody\Idarucizumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Idarucizumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Idarucizumab (substance)

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Idarucizumab (substance)
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Idarucizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3304446011 Idarucizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3304447019 Idarucizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

72121000195115 Idarucizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

817281000172110 idarucizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

57591000195111 idarucizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Idarucizumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Idarucizumab (substance)	Is a	Antidote (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing idarucizumab (medicinal product)	Has active ingredient	True	Idarucizumab (substance)	Inferred relationship	Some	1
Idarucizumab-containing product in parenteral dose form	Has active ingredient	True	Idarucizumab (substance)	Inferred relationship	Some	1
Idarucizumab only product	Has active ingredient	True	Idarucizumab (substance)	Inferred relationship	Some	1
Idarucizumab only product in parenteral dose form	Has active ingredient	True	Idarucizumab (substance)	Inferred relationship	Some	1
Product containing precisely idarucizumab 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	Has precise active ingredient	True	Idarucizumab (substance)	Inferred relationship	Some	1
Product containing precisely idarucizumab 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	Has basis of strength substance (attribute)	True	Idarucizumab (substance)	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set